Simile raises more than $200 million at a $2 billion post-money valuation. Key points * Greenoaks led the Series B, with Index Ventures, Hanabi, Bain Capital Ventures, A*, Factory, CVS Health Ventures and new investor Definition participating.[[1]] * The $2 billion figure is a post-money valuation; Simile did not disclose its pre-money valuation, share price or whether the round included secondary sales.[[1]] * Simile says revenue has increased fivefold since its February launch, but it provided no revenue figure, customer count or contract values.[[1]] Simile has raised more than $200 million in a Series B led by Greenoaks, giving the artificial-intelligence startup a $2 billion post-money valuation just five months after its public launch. Returning investors Index Ventures, Hanabi, Bain Capital Ventures, A*, Factory and CVS Health Ventures participated, while Definition joined as a new investor.[[1]] The Palo Alto company builds AI models intended to simulate how people and groups respond to products, marketing, pricing and other decisions. Simile says customers include CVS Health, Wealthfront, Deloitte and Gallup, and that Fortune 100 enterprises have run tens of millions of simulations through its technology.[[1]] Those product and usage figures were reported by the company and have not been independently audited. Rapid growth, limited financial disclosure. Simile said revenue has grown fivefold since it launched in February and that its workforce now exceeds 50 people. It did not provide starting or current revenue, annual recurring revenue, customer totals, pricing or retention figures, making the valuation difficult to assess against conventional software metrics.[[1]] The company also did not explain whether the $2 billion valuation resulted solely from the price paid for newly issued shares or whether the financing contained secondary transactions. The company says its models begin with data from real people and are checked against human responses. Its website claims more than 7,000 evaluations across demographic groups and enterprise use cases, along with a confidence model designed to estimate the accuracy of each simulation.[[2]] Simile has not released enough underlying commercial validation data for outsiders to test those claims broadly. Simile said the proceeds would accelerate its work and support hiring researchers, engineers, designers and operators, without providing a spending breakdown.[[1]] Index Ventures led its $100 million Series A announced on February 12, alongside Bain Capital Ventures, A* and Hanabi Capital and several individual AI investors.[[3]] TechCrunch first reported the new financing as a $200 million Series B.[[4]] Discover more Computer Science Market intelligence reports AI market analysis Discover more AI infrastructure solutions Dictionaries & Encyclopedias Web Apps & Online Tools At the intersection of AI, tech, and markets. The stories that matter, in one email. Free - unsubscribe anytime.

Simile has raised over $200 million at a $2 billion post-money valuation, led by Greenoaks, to accelerate our mission: simulating all eight billion people.